These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 20074989)

  • 21. Screening for newborn fatty acid oxidation disorders in Chongqing and the follow-up of confirmed children.
    Chen M; Yin Y; Liu H; Peng Y; Ye L; Luo Q; Miao J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 51(3):290-297. PubMed ID: 36207828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic and molecular features of Thai patients with primary carnitine deficiency.
    Liammongkolkul S; Boonyawat B; Vijarnsorn C; Tim-Aroon T; Wasant P; Vatanavicharn N
    Pediatr Int; 2023 Jan; 65(1):e15404. PubMed ID: 36321377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carnitine transporter defect due to a novel mutation in the SLC22A5 gene presenting with peripheral neuropathy.
    Makhseed N; Vallance HD; Potter M; Waters PJ; Wong LT; Lillquist Y; Pasquali M; Amat di San Filippo C; Longo N
    J Inherit Metab Dis; 2004; 27(6):778-80. PubMed ID: 15617188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mutational analysis of SLC22A5 gene in eight patients with systemic primary carnitine deficiency].
    Lin Y; Lin W; Yu K; Zheng F; Zheng Z; Fu Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Feb; 34(1):35-39. PubMed ID: 28186590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21).
    Tamai I
    Biopharm Drug Dispos; 2013 Jan; 34(1):29-44. PubMed ID: 22952014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A missense mutation in the OCTN2 gene associated with residual carnitine transport activity.
    Wang Y; Kelly MA; Cowan TM; Longo N
    Hum Mutat; 2000; 15(3):238-45. PubMed ID: 10679939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial fatty acid oxidation disorders in Thai infants: a report of 3 cases.
    Wasant P; Matsumoto I; Naylor E; Liammongkolkul S
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S710-9. PubMed ID: 12403251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carnitine transporter defect: diagnosis in asymptomatic adult women following analysis of acylcarnitines in their newborn infants.
    Vijay S; Patterson A; Olpin S; Henderson MJ; Clark S; Day C; Savill G; Walter JH
    J Inherit Metab Dis; 2006 Oct; 29(5):627-30. PubMed ID: 16865412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Newborn screening for carnitine palmitoyltransferase II deficiency using (C16+C18:1)/C2: Evaluation of additional indices for adequate sensitivity and lower false-positivity.
    Tajima G; Hara K; Tsumura M; Kagawa R; Okada S; Sakura N; Maruyama S; Noguchi A; Awaya T; Ishige M; Ishige N; Musha I; Ajihara S; Ohtake A; Naito E; Hamada Y; Kono T; Asada T; Sasai H; Fukao T; Fujiki R; Ohara O; Bo R; Yamada K; Kobayashi H; Hasegawa Y; Yamaguchi S; Takayanagi M; Hata I; Shigematsu Y; Kobayashi M
    Mol Genet Metab; 2017 Nov; 122(3):67-75. PubMed ID: 28801073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Newborn screening for primary carnitine deficiency in Quanzhou, China.
    Lin W; Wang K; Zheng Z; Chen Y; Fu C; Lin Y; Chen D
    Clin Chim Acta; 2021 Jan; 512():166-171. PubMed ID: 33181153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of carnitine and fatty acid oxidation and its defects in infantile epilepsy.
    Tein I
    J Child Neurol; 2002 Dec; 17 Suppl 3():3S57-82; discussion 3S82-3. PubMed ID: 12597056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of dye-binding/high-resolution thermal denaturation for the identification of mutations in the SLC22A5 gene.
    Dobrowolski SF; McKinney JT; Amat di San Filippo C; Giak Sim K; Wilcken B; Longo N
    Hum Mutat; 2005 Mar; 25(3):306-13. PubMed ID: 15714519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A founder mutation (R254X) of SLC22A5 (OCTN2) in Chinese primary carnitine deficiency patients.
    Tang NL; Hwu WL; Chan RT; Law LK; Fung LM; Zhang WM
    Hum Mutat; 2002 Sep; 20(3):232. PubMed ID: 12204000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A cause of dilated cardiomyopathy in a child: primary carnitine deficiency].
    Baragou S; Pio M; Di Bernardo S; Ksontini TB; Dommange SJ; Bonafe L; Meijboom E; Sekarski N
    Ann Cardiol Angeiol (Paris); 2014 Apr; 63(2):107-10. PubMed ID: 22260907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deficiency of the carnitine transporter (OCTN2) with partial N-acetylglutamate synthase (NAGS) deficiency.
    Hwu WL; Chien YH; Tang NL; Law LK; Lin CY; Lee NC
    J Inherit Metab Dis; 2007 Oct; 30(5):816. PubMed ID: 17703373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for neonatal inherited metabolic disorders by tandem mass spectrometry in Guangzhou.
    Tang C; Tan M; Xie T; Tang F; Liu S; Wei Q; Liu J; Huang Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 50(4):463-471. PubMed ID: 34704419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exclusive cardiac dysfunction in familial primary carnitine deficiency cases: a genotype-phenotype correlation.
    Yamak A; Bitar F; Karam P; Nemer G
    Clin Genet; 2007 Jul; 72(1):59-62. PubMed ID: 17594400
    [No Abstract]   [Full Text] [Related]  

  • 38. Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy.
    Tein I; De Vivo DC; Bierman F; Pulver P; De Meirleir LJ; Cvitanovic-Sojat L; Pagon RA; Bertini E; Dionisi-Vici C; Servidei S
    Pediatr Res; 1990 Sep; 28(3):247-55. PubMed ID: 2235122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotype-phenotype correlation in primary carnitine deficiency.
    Rose EC; di San Filippo CA; Ndukwe Erlingsson UC; Ardon O; Pasquali M; Longo N
    Hum Mutat; 2012 Jan; 33(1):118-23. PubMed ID: 21922592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences between acylcarnitine profiles in plasma and bloodspots.
    de Sain-van der Velden MG; Diekman EF; Jans JJ; van der Ham M; Prinsen BH; Visser G; Verhoeven-Duif NM
    Mol Genet Metab; 2013; 110(1-2):116-21. PubMed ID: 23639448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.